氰基丙烯酸酯闭合后再通的管理:单中心经验
单中心回顾335例接受氰基丙烯酸酯闭合(CAC)的患者,识别23例再通并评估二次治疗。超声引导泡沫硬化剂(UGFS)15例中12例(80%)成功闭塞;激光消融(EVLA)和射频消融(RFA)在部分病例技术可行。离体实验提示激光消融可致CA变形碳化,RFA无结构改变。
要点
- CAC后再通表现为不连续、不规则模式。
- UGFS对CAC后再通闭塞成功率80%(12/15)。
- EVLA和RFA可用于选择性病例,但激光可能致CA变形。
核心结论
- CAC后再通模式异质且常不连续,UGFS在多数病例中可作为有效一线治疗。
- EVLA和RFA在选择性病例中技术可行且未观察到并发症。
- 激光消融可能与聚合CA存在独特相互作用,需进一步临床验证。
研究设计与样本
- 识别23例再通病例,分析UGFS、1470 nm EVLA或RFA的治疗结果。
- 补充离体实验观察激光消融、RFA和聚多卡醇对CA聚合物的影响。
主要发现
- 23例再通病例中,再通模式常为不连续和不规则。
- UGFS治疗15例,12例(80%)成功闭塞。
- EVLA治疗2例均成功闭塞,但超声观察到CA变形。
- RFA治疗7例均完成且无CA变形,闭塞良好。
- 离体实验中激光消融致CA变形碳化,温度达193至200 °C;RFA无结构改变,温度80至93 °C;聚多卡醇对CA无可见影响。
关键数值与推荐
- 再通定义为随访双功超声显示治疗段内部分或完全恢复管腔血流。
- 再通详细定义:反流时间≥0.5秒、可压缩、节段长度≥5 cm且有症状。
- UGFS成功闭塞率80%(12/15)。
临床怎么用
- 对于CAC后再通,可考虑UGFS作为一线治疗。
- 选择EVLA或RFA时需权衡CA变形风险,尤其激光消融。
局限性
- 回顾性单中心设计,样本量小(23例再通)。
- 离体实验为初步探索性观察,需进一步临床验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Cyanoacrylate closure (CAC) is an established treatment for lower-extremity varicose veins. Recanalization after CAC is an uncommon but clinically relevant event for which optimal management strategies have not been well described. The objective of this study was to retrospectively review cases of CAC recanalization at a single center and to descriptively evaluate the secondary treatment approaches, including ultrasound-guided foam sclerotherapy (UGFS), endovenous laser ablation (EVLA), and radiofrequency ablation (RFA). METHODS: We retrospectively reviewed 335 patients who underwent CAC procedures at Kannai Medical Clinic between August 2020 and November 2025. Recanalization was defined as partial or complete restoration of luminal flow within the treated vein segment on duplex ultrasound during follow-up. The detailed definition of recanalization is as follows: reflux flow of 0.5 seconds or more, being compressible, a segment length of 5 cm or more, and symptomatic cases. Twenty-three cases with recanalization were identified and analyzed. Treatment outcomes following UGFS, 1470 nm EVLA, or RFA were assessed. In addition, as a supplement, a preliminary ex vivo experiment was conducted to observe the effects of laser ablation, RFA, and polidocanol on cyanoacrylate (CA) polymerized with blood. RESULTS: Among the 23 recanalization cases, recanalization patterns were frequently discontinuous and irregular. UGFS was performed in 15 cases, and recanalization was successfully occluded in 12 cases (80%). EVLA was performed in 2 cases; one required multiple direct punctures because of complex recanalization, and recanalization was successfully occluded in both cases. However, deformation of CA was observed by ultrasound during laser ablation. RFA was performed in 7 cases using multiple direct punctures with a 12G needle with a plastic cannula; all procedures were completed without CA deformation and with favorable occlusion. In the ex vivo experiment, laser ablation caused CA deformation and carbonization, and temperature measurement reached 193 to 200 °C during ablation in CA, whereas RFA produced no structural changes with 80 to 93 °C temperature. Polidocanol had no observable effect on CA. CONCLUSIONS: Recanalization after CAC demonstrates heterogeneous and often discontinuous patterns. UGFS achieved successful occlusion at an 80% success rate. UGFS may be an effective first-line treatment in many cases. EVLA and RFA were technically feasible in selected cases, without observed complications. Laser ablation may have unique interactions with polymerized CA, as suggested by preliminary experimental observations. However, these observations are exploratory and require further clinical validation. Careful consideration is warranted when selecting secondary treatment modalities for CAC recanalization.
引用
- Murayama T, Sujino K, Yamashita M, et al. Management of recanalization after cyanoacrylate closure: A single-center experience. J Vasc Surg Venous Lymphat Disord. 2026. PMID: 42331094. doi:10.1016/j.jvsv.2026.102560
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。